On January 21, 2019, TechCare Corp.’s board of directors appointed Ningzhou Zhang to serve as a member of the board of directors of the company subject and upon the closing of the initial closing under the Subscription Agreement. Ningzhou Zhang, age 56, serves as the chief executive officer of China-Israel Biological Technology Co. Ltd. Since 2013, Mr. Zhang is a private investor who works as a financial advisor to major Chinese private equity funds regarding investments in Israel. He also serves as a senior VP and general counsel of Avantalion Consulting Group as well as General Counsel of CA Investment Company. Mr. Zhang has also participated in many Chinese-state-owned companies listed in New York.